SEC Form 4 · accession 0001209191-15-078220
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven Lo
Officer — VP Commercial Operations
Period of report
Oct 26, 2015
Accepted (ET)
Nov 3, 2015 · 9:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Nov 2, 2015 | S | 12,500 | $4.00 | D | 0 | D | |
| Common stockF1 | Oct 26, 2015 | M | 12,500 | $3.29 | A | 12,500 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock optionF2,F3 | $3.29 | Oct 26, 2015 | M | 12,500 | A | — | Feb 17, 2025 | Common stock | 12,500 | 0 | D |
Explanation of responses
- F1Exercise and hold.
- F2Fully exerciseable.
- F331,499 shares were cancelled upon termination of employment.